As of 2024-12-11, the Fair Value of ImmuPharma PLC (IMM.L) is -9.93 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.13 GBP, the upside of ImmuPharma PLC is -980.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -6.12 | -6.86 | -8.17 | -3.81 | -2.92 | -5.58 |
| YoY growth | 15.03% | -12.02% | -19.15% | 53.42% | 23.26% | 12.11% |
| Market Cap (mil) | 4.55 |
| P/E | |
| Forward P/E |
| EPS | -0.82 |
| Avg earnings growth rate | 12.11% |
| TTM earnings | -3.31 |